ClinicalTrials.Veeva

Find clinical trials for Lung Cancer in San Antonio, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Non-Small-Cell Lung Carcinoma
Cancer
Carcinoma
Small Cell Lung Carcinoma
Squamous Cell Carcinoma of Head and Neck
Colorectal Cancer
Triple Negative Breast Cancer

Lung Cancer trials near San Antonio, TX, USA:

Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07)

with pemetrexed and platinum chemotherapy in participants with no prior therapy for advanced or metastatic non-squamous non-small cell lung ...

Enrolling
Metastatic Non Small Cell Lung Cancer
Drug: Cisplatin
Drug: Datopotamab Deruxtecan

Phase 3

Daiichi Sankyo
Daiichi Sankyo

San Antonio, Texas, United States and 139 other locations

the safety and tolerability of itacitinib in combination with osimertinib in subjects with locally advanced or metastatic non-small cell lung...

Active, not recruiting
Lung Cancer
Drug: Itacitinib
Drug: Osimertinib

Phase 1, Phase 2

Incyte
Incyte

San Antonio, Texas, United States and 30 other locations

and pemetrexed, with or without an anti-PD-1 antibody (pembrolizumab or zimberelimab), in participants with non-squamous Non-Small Cell Lung ...

Active, not recruiting
Non Small Cell Lung Cancer Metastatic
Nonsquamous Nonsmall Cell Neoplasm of Lung
Drug: Zimberelimab
Drug: Etrumadenant

Phase 1

Arcus Biosciences
Arcus Biosciences

San Antonio, Texas, United States and 22 other locations

for the treatment of locally advanced or metastatic non-small cell lung cancer. Some lung cancers are due to muta...

Active, not recruiting
Non-Small Cell Lung Cancer
Drug: Pemetrexed/Carboplatin
Drug: Pemetrexed/Cisplatin

Phase 3

AstraZeneca
AstraZeneca

San Antonio, Texas, United States and 152 other locations

A Phase 1/1b dose finding study to determine the OBD(s) and RP2D(s) of BMF-219, a covalent menin inhibitor small molecule, in subjects with KRAS muta...

Enrolling
Stage III Non-small Cell Lung Cancer
Stage III Pancreatic Cancer
Drug: BMF-219

Phase 1

Biomea Fusion

San Antonio, Texas, United States and 22 other locations

This is an open-label, non-controlled study conducted in two parts - Part A (dose escalation) followed by Part B (dose expansion).

Active, not recruiting
Colorectal Cancer
Pancreatic Cancer
Drug: NBF-006

Phase 1

Nitto BioPharma

San Antonio, Texas, United States and 8 other locations

The main purpose of the study is to evaluate the safety of GDC-1971 in combination with either osimertinib or cetuximab. The study consists of a dose...

Enrolling
Non-Small Cell Lung Cancer
Colorectal Cancer
Drug: GDC-1971
Drug: Cetuximab

Phase 1

Genentech
Genentech

San Antonio, Texas, United States and 9 other locations

deruxtecan (Dato-DXd) in combination with pembrolizumab versus pembrolizumab alone in participants with advanced or metastatic non-small cell lung...

Enrolling
Metastatic Non Small Cell Lung Cancer
Drug: Datopotamab Deruxtecan
Drug: Pembrolizumab

Phase 3

Daiichi Sankyo
Daiichi Sankyo

San Antonio, Texas, United States and 229 other locations

maintenance therapy in participants with extensive-stage small-cell lung cancer (ES-SCLC) after first-line induction therapy with c...

Active, not recruiting
Small-Cell Lung Cancer
Drug: Etoposide
Drug: Atezolizumab

Phase 3

Roche
Roche

San Antonio, Texas, United States and 111 other locations

(Dato-DXd) in combination with pembrolizumab with or without platinum chemotherapy in participants with advanced or metastatic non-small cell lung...

Active, not recruiting
Advanced or Metastatic NSCLC
Drug: Cisplatin
Drug: KEYTRUDA®

Phase 1

Daiichi Sankyo
Daiichi Sankyo

San Antonio, Texas, United States and 23 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems